Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1452, 2004-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
QOL improves following superior lumiracoxib effect in OA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 460, 2004-01 ,pp. :
Alefacept improves QOL in psoriasis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 399, 2003-01 ,pp. :
Erlotinib improves QOL in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. :
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 308, 2001-01 ,pp. :
Antiepileptic substitution improves QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 663, 2012-01 ,pp. :